Exane Derivatives’s ZoomInfo Technologies GTM Stock Holding History

Exane Derivatives’s Portfolio GTM Stock Details GTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,116	Closed	-$66.7K	–	1035
2022 Q1	$66.7K	Buy	+1,116	New	+$59.9K	0.02%	533
2021 Q4	–	Sell	-3,024	Closed	-$185K	–	1085
2021 Q3	$185K	Buy	3,024 +1,669	+123%	+$99.8K	0.04%	412
2021 Q2	$71.7K	Buy	1,355 +1,332	+5,791%	+$62.6K	0.02%	585
2021 Q1	$1.13K	Buy	+23	New	+$1.16K	﹤0.01%	721

Other funds holding GTM

TA Associates Boston, Massachusetts $4.01M AUM 59.82% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Exane Derivatives's GTM Position: Q2 2022 in Review

Exane Derivatives sold out of ZoomInfo Technologies (GTM) in Q2 2022, closing a stake of 1,116 shares — an estimated $66.7K sold.

Exane Derivatives first reported a position in GTM in Q1 2021 and held it in 4 quarters. The position peaked at $185K in Q3 2021. 362 funds tracked by Wall St. Rank hold GTM as of Q2 2022.

Exane Derivatives reported no remaining ZoomInfo Technologies position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 1,116 ZoomInfo Technologies shares in Q2 2022, an estimated $66.7K.
Exane Derivatives first reported a position in ZoomInfo Technologies in Q1 2021 and held it in 4 quarters.
Exane Derivatives's ZoomInfo Technologies position peaked at $185K in Q3 2021.
362 funds tracked by Wall St. Rank held ZoomInfo Technologies as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.